No Data
No Data
Indivior (LON:INDV) Shareholder Returns Have Been Enviable, Earning 366% in 5 Years
Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $16
Indivior Management to Meet Virtually With Northland
Indivior to Engage With Investors at Healthcare Conference
Indivior Shares Sublocade Trial Findings at CSAM Conference
Indivior Data Shows Rapid Initiation With Once-Monthly SUBLOCADE Significantly Improves Retention In Opioid Use Disorder Patients, Especially Among Fentanyl-Positive Participants; Study Also Administered Second SUBLOCADE Injection A Week Later Vs....
No Data